Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA6 | P23280 | 4/20 | 0.40 |
| ▸ | CA7 | P43166 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA3 | P07451 | 3/20 | 0.40 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA5A | P35218 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylenediamine SCHEMBL1334048 | 1.00 | — | — | |
| Ethylenediamine SCHEMBL31422783 | 1.00 | — | — | |
| Ethylenediamine SCHEMBL948903 | 1.00 | — | — | |
| Ethylenediamine SCHEMBL27879448 | 0.93 | — | — | |
| Ethylenediamine SCHEMBL8726062 | 0.93 | MAPT (0.46) | NFKB1TSHRCA12CA6CA7 | |
| Ethylenediamine SCHEMBL23245690 | 0.93 | MAPT (0.46) | NFKB1TSHRCA12CA6CA7 | |
| Ethylenediamine SCHEMBL11315631 | 0.93 | — | — | |
| Ethylenediamine SCHEMBL8365876 | 0.93 | — | — | |
| Ethylenediamine SCHEMBL37647 | 0.91 | — | — | |
| Ethylenediamine SCHEMBL3083 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113522287-A | Carbon-supported metal catalyst with hierarchical pore structure, preparation method and application thereof | 中科合成油技术有限公司 | 2021-10-22 | — | — | CN | claimed |
| EP-3044329-B1 | DEVICE PREPARATION USING CONDENSED NUCLEIC ACID PARTICLES | LIFE TECHNOLOGIES CORP (US) | 2020-04-22 | — | — | EP | claimed |
| CN-107754793-B | Porous carbon loaded Fischer-Tropsch synthesis catalyst and preparation method and application thereof | 中科合成油技术有限公司 | 2020-04-17 | — | — | CN | claimed |
| EP-2652052-B1 | LIQUID ELECTROPHOTOGRAPHIC INK | HEWLETT PACKARD DEVELOPMENT CO (US) | 2016-09-07 | — | — | EP | claimed |
| EP-3044329-A1 | DEVICE PREPARATION USING CONDENSED NUCLEIC ACID PARTICLES | Life Technologies Corporation (US) | 2016-07-20 | — | — | EP | claimed |
| WO-2015038954-A1 | DEVICE PREPARATION USING CONDENSED NUCLEIC ACID PARTICLES | Life Technologies Corporation (US) | 2015-03-19 | — | — | WO | claimed |
| US-20120046471-A1 | PROCESS FOR PREPARING ORGANIC COMPOUNDS BY A TRANSITION METAL-CATALYSED CROSS-COUPLING REACTION OF AN ARYL-X, HETEROARYL-X, CYCLOALKENYL-X OR ALKENYL-X COMPOUND WITH AN ALKYL, ALKENYL, CYCLOALKYL OR CYCLOALKENYL HALIDE | SALTIGO GMBH (DE) | 2012-02-23 | — | — | US | claimed |
| US-8030520-B2 | Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide | SALTIGO GMBH (DE) | 2011-10-04 | — | — | US | claimed |
| US-20090247764-A1 | PROCESS FOR PREPARING ORGANIC COMPOUNDS BY A TRANSITION METAL-CATALYSED CROSS-COUPLING REACTION OF AN ARYL-X, HETEROARYL-X, CYCLOALKENYL-X OR ALKENYL-X COMPOUND WITH AN ALKYL, ALKENYL, CYCLOALKYL OR CYCLOALKENYL HALIDE | SALTIGO GMBH (DE) | 2009-10-01 | — | — | US | claimed |
| US-6403343-B2 | PLANT EXTRACT | MITSUI CHEMICALS, INC. (JP) | 2002-06-11 | — | — | US | claimed |
| EP-0683232-A1 | PROCESS FOR PRODUCING TAXANE DITERPENE AND METHOD OF HARVESTING CULTRED CELL CAPABLE OF PRODUCING TAXANE DITERPENE IN HIGH YIELD | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-11-22 | — | — | EP | claimed |
| EP-0449969-B1 | PHOTORESIST COMPOSITIONS CONTAINING COBALT (III) COMPOUND AND REDOX TRANSFER LIGAND | EASTMAN KODAK CO (US) | 1994-02-16 | — | — | EP | claimed |
| EP-0204526-B1 | SILICONE ELASTOMERS | XEROX CORPORATION (US) | 1992-06-10 | — | — | EP | claimed |
| EP-0449969-A1 | PHOTORESIST COMPOSITIONS CONTAINING COBALT (III) COMPOUND AND REDOX TRANSFER LIGAND. | EASTMAN KODAK CO (US) | 1991-10-09 | — | — | EP | claimed |
| US-4968586-A | HIGH SPEED LITHOGRAPHIC PRINTING PLATES | EASTMAN KODAK COMPANY (US) | 1990-11-06 | — | — | US | claimed |
| WO-1990007730-A1 | PHOTORESIST COMPOSITIONS CONTAINING COBALT (III) COMPOUND AND REDOX TRANSFER LIGAND | EASTMAN KODAK COMPANY (US) | 1990-07-12 | — | — | WO | claimed |
| US-4925895-A | TRANSITION METAL COMPLEX FOR OXIDATION RESISTANCE, FUSER ROLLS IN ELECTROGRAPHIC MACHINES | XEROX CORPORATION (US) | 1990-05-15 | — | — | US | claimed |
| US-4777087-A | MIXTURE OF POLYSILOXANE AND COMPLEX OF TRANSITION METAL SALT AND LIGAND | XEROX CORPORATION (US) | 1988-10-11 | — | — | US | claimed |
| EP-0204526-A2 | Silicone elastomers | XEROX CORPORATION (US) | 1986-12-10 | — | — | EP | claimed |
| US-4615777-A | Method and composition for reducing the voltage in an electrolytic cell | OLIN CORPORATION (US) | 1986-10-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247764-A1 | PROCESS FOR PREPARING ORGANIC COMPOUNDS BY A TRANSITION METAL-CATALYSED CROSS-COUPLING REACTION OF AN ARYL-X, HETEROARYL-X, CYCLOALKENYL-X OR ALKENYL-X COMPOUND WITH AN ALKYL, ALKENYL, CYCLOALKYL OR CYCLOALKENYL HALIDE | MLX, PYM1, CBR3 | NFKB1 3620/4885TSHR 191/4885CA12 2471/4885 |
| US-20120046471-A1 | PROCESS FOR PREPARING ORGANIC COMPOUNDS BY A TRANSITION METAL-CATALYSED CROSS-COUPLING REACTION OF AN ARYL-X, HETEROARYL-X, CYCLOALKENYL-X OR ALKENYL-X COMPOUND WITH AN ALKYL, ALKENYL, CYCLOALKYL OR CYCLOALKENYL HALIDE | TIMCC, ZFX, TSNAX | NFKB1 2204/4885TSHR 526/4885CA12 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.